Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Next Generation iBOT

K-Number: K172601 · 2018-03-02

Decision Date2018-03-02
Product CodeIMK
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Next Generation iBOT is a medical device manufactured by Deka Research & Development Corp.. It received FDA 510(k) clearance on 2018-03-02 under approval number K172601. The device is classified under product code IMK. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Next Generation iBOT?

Next Generation iBOT is a medical device that received FDA 510(k) clearance on 2018-03-02. It is manufactured by Deka Research & Development Corp.. The 510(k) number is K172601.

When was Next Generation iBOT approved by the FDA?

Next Generation iBOT received FDA 510(k) clearance on 2018-03-02, under approval number K172601.

What company makes Next Generation iBOT?

Next Generation iBOT is manufactured by Deka Research & Development Corp..

What is the FDA product code for Next Generation iBOT?

The FDA product code for Next Generation iBOT is IMK.

Other Devices by Deka Research & Development Corp.

Related Devices (Code: IMK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.